These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
776 related articles for article (PubMed ID: 21484931)
1. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome. Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931 [TBL] [Abstract][Full Text] [Related]
2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
3. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432 [TBL] [Abstract][Full Text] [Related]
4. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481 [TBL] [Abstract][Full Text] [Related]
6. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
7. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
8. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
9. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965 [TBL] [Abstract][Full Text] [Related]
11. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome. Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321 [TBL] [Abstract][Full Text] [Related]
12. A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome. Id Said B; Malkin D Cancer Genet; 2015; 208(1-2):47-51. PubMed ID: 25683625 [TBL] [Abstract][Full Text] [Related]
13. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families. Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494 [TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139 [TBL] [Abstract][Full Text] [Related]
15. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome. Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821 [TBL] [Abstract][Full Text] [Related]
16. High frequency of de novo mutations in Li-Fraumeni syndrome. Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T; J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570 [TBL] [Abstract][Full Text] [Related]
18. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family. Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898 [TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation. Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190 [TBL] [Abstract][Full Text] [Related]
20. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Palmero EI; Achatz MI; Ashton-Prolla P; Olivier M; Hainaut P Curr Opin Oncol; 2010 Jan; 22(1):64-9. PubMed ID: 19952748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]